Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.410-0.025(-1.74%)INC SPÓŁKA AKCYJNA
GPW - Akcje/PDA - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
Kalaris Therapeutics, Inc.
The post Kalaris Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Oklo Inc. (OKLO) reports Q1 2026 results on May 12 with investors focused less on near-term revenue and more on...
The post Oklo (OKLO) Heads Into Q1 With Regulatory Momentum but No Room for Narrative Drift first appeared on Alphastreet.
Nuwellis, Inc.
The post Nuwellis Releases Q1 2026 Financial Results first appeared on Alphastreet.
PMV Pharmaceuticals, Inc.
The post PMV Pharmaceuticals Releases Q1 2026 Financial Results first appeared on Alphastreet.
ACM Research, Inc. shares tumbled 6.2% on Tuesday, falling to $60.63 as a broad selloff hammered semiconductor equipment makers across the board. The compan...
The post ACM Research Drops 6.2% Amid Sector-Wide Selling first appeared on Alphastreet.
Netlist, Inc.
The post Netlist Releases Q1 2026 Financial Results first appeared on Alphastreet.
Strong beat. Qnity Electronics, Inc. (NYSE:Q) delivered a decisive earnings beat in Q1 2026, posting adjusted EPS of $1.08 versus the Street's $0.94 expecta...
The post Qnity Electronics Delivers 14.9% Q1 2026 Upside, Revenue Up 18% first appeared on Alphastreet.
Imunon, Inc.
The post Imunon Releases Q1 2026 Financial Results first appeared on Alphastreet.
Ovid Therapeutics Inc.
The post Ovid Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Achieve Life Sciences, Inc.
The post Achieve Life Sciences Releases Q1 2026 Financial Results first appeared on Alphastreet.
Veritone, Inc.
The post Veritone Releases Q1 2026 Financial Results first appeared on Alphastreet.
Coya Therapeutics, Inc.
The post Coya Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Xilio Therapeutics, Inc.
The post Xilio Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Sagimet Biosciences Inc.
The post Sagimet Biosciences Releases Q1 2026 Financial Results first appeared on Alphastreet.
Ambiq Micro Inc reported a narrower-than-expected loss for its first quarter of 2026, posting a Non-GAAP loss of $0.
The post Ambiq Micro Releases Q1 2026 Financial Results first appeared on Alphastreet.
Opus Genetics, Inc.
The post Opus Genetics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Broadwind, Inc.
The post Broadwind Releases Q1 2026 Financial Results first appeared on Alphastreet.
Olema Pharmaceuticals, Inc.
The post Olema Pharmaceuticals Releases Q1 2026 Financial Results first appeared on Alphastreet.
C4 Therapeutics, Inc.
The post C4 Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Unicycive Therapeutics, Inc.
The post Unicycive Therapeutics Releases Q1 2026 Financial Results first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 21 210 770 |
| Enterprise Value: | 20 823 770 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
Biznesradar bez reklam? Sprawdź BR Plus
